Which drugs does patent 6,939,964 protect, and when does it expire?
Patent 6,939,964 protects SUSTIVA and ATRIPLA and is included in three NDAs. There have been zero Paragraph IV challenges on Sustiva and
Protection for SUSTIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-two patent family members in twenty countries.